Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Millan

Showing results (71-80 of 188) with videos related to

Pageof 19
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 4, 2015
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disordersMark J Millan, Guy M Goodwin, Andreas Meyer-Lindenberg, et al.
Journal of Neurochemistry|October 11, 2003
Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropiniroleRoberto Maggio, Marco Scarselli, Francesca Novi, et al.
Molecular Pharmacology|August 16, 2002
Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed traffickingDidier Cussac, Adrian Newman-Tancredi, Delphine Duqueyroix, et al.
Psychopharmacology|September 18, 2012
Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidineNicholas E Clifton, Nadège Morisot, Sylvie Girardon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 25, 2015
60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progressMark J Millan, Guy M Goodwin, Andreas Meyer-Lindenberg, et al.
Journal of Neuroscience Methods|September 17, 2011
Simultaneous quantification of D- vs. L-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: differential modulation by N-methyl-D-aspartate (NMDA) and other pharmacological agentsAlain Gobert, Jean-Michel Rivet, Rodolphe Billiras, et al.
Molecular Pharmacology|October 19, 2010
Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptorsClotilde Mannoury la Cour, Marie-Josèphe Salles, Valérie Pasteau, et al.
Parkinsonism & Related Disorders|July 1, 2008
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formationRoberto Maggio, Francesca Novi, Mario Rossi, et al.
Neuroscience Applied|July 14, 2025
Prospects for improved prevention and treatment of neuropsychiatric disorders: <i>Neuroscience Applied</i>Andreas Meyer-Lindenberg, Suzanne L Dickson, Mark J Millan, et al.
Leukemia Research|November 1, 2011
Evidence for functional trace amine associated receptor-1 in normal and malignant B cellsAgata M Wasik, Mark J Millan, Thomas Scanlan, et al.
Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 4, 2015
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disordersMark J Millan, Guy M Goodwin, Andreas Meyer-Lindenberg, et al.
Journal of Neurochemistry|October 11, 2003
Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropiniroleRoberto Maggio, Marco Scarselli, Francesca Novi, et al.
Molecular Pharmacology|August 16, 2002
Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed traffickingDidier Cussac, Adrian Newman-Tancredi, Delphine Duqueyroix, et al.
Psychopharmacology|September 18, 2012
Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidineNicholas E Clifton, Nadège Morisot, Sylvie Girardon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 25, 2015
60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progressMark J Millan, Guy M Goodwin, Andreas Meyer-Lindenberg, et al.
Journal of Neuroscience Methods|September 17, 2011
Simultaneous quantification of D- vs. L-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: differential modulation by N-methyl-D-aspartate (NMDA) and other pharmacological agentsAlain Gobert, Jean-Michel Rivet, Rodolphe Billiras, et al.
Molecular Pharmacology|October 19, 2010
Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptorsClotilde Mannoury la Cour, Marie-Josèphe Salles, Valérie Pasteau, et al.
Parkinsonism & Related Disorders|July 1, 2008
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formationRoberto Maggio, Francesca Novi, Mario Rossi, et al.
Neuroscience Applied|July 14, 2025
Prospects for improved prevention and treatment of neuropsychiatric disorders: <i>Neuroscience Applied</i>Andreas Meyer-Lindenberg, Suzanne L Dickson, Mark J Millan, et al.
Leukemia Research|November 1, 2011
Evidence for functional trace amine associated receptor-1 in normal and malignant B cellsAgata M Wasik, Mark J Millan, Thomas Scanlan, et al.
Pageof 19